πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7833722

Ligands for G protein-coupled receptor protein and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825269

Ligands for nematode nuclear receptors and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7816372

6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Ligand Pharmaceuticals Incorporated Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786149

Thiadiazoles as CXC- and CC- chemokine receptor ligands

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786282

Nucleic acid molecules encoding TNF-Ξ± ligand polypeptides having a CD154 domain

The Regents of the University of California Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754206

Method for treating cancer using a Notch4 ligand antagonist

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749984

Computer-based model for identification and characterization of non-competitive inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7741365

Peripheral cannabinoid receptor (CB2) selective ligands

UNIVERSITY OF CONNECTICUT Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7727980

Tricyclic androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7696246

Bicyclic androgen and progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691895

Thrombopoietin activity modulating compounds and methods

Ligand Pharmaceuticals Incorporated Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7671174

Ligand to GPR8

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666867

Heteroindanes: a new class of potent cannabimimetic ligands

UNIVERSITY OF CONNECTICUT Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662380

ZAQ ligand-1 antibodies and uses thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632932

Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622444

Methods for using OX-40 ligand to enhance an antigen specific immune response

Sisters of Providence in Oregon Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618632

Method of treating or ameliorating an immune cell associated pathology using GITR ligand a

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7615208

Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and meth

The Board of Regents of the University of Texas System Β· Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576175

Alpha-4 beta-1 integrin ligands for imaging and therapy

The Regents of the University of California Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541429

Comparative ligand mapping from MHC positive cells

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534868

Human antibodies to human delta like ligand 4

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517661

Methods of screening for ligands for FPRL2

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488806

Human antibodies to human delta like ligand 4

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485660

Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof

The Regents of the University of California Β· Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted